DAXOR CORP

DXR
United States Fiscal year ends December CIK 0000027367

What the insiders did Net buying

By person

10 insiders · 53 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Joseph Feldschuh
10% owner
$1.46M (1)
$650.53K (2)
+$811.47K
2,774,455
$25.16M
+3.2%
Jonathan Adam Feldschuh
Chief Scientific Officer
— (2)
$357.58K (1)
−$357.58K
78,908
$715.70K
+241.6%
Michael Richard Feldschuh
Chief Executive Officer
$167.25K (23)
$341.12K (1)
−$173.87K
243,694
$2.21M
+153.5%
Robert J Michel
Chief Financial Officer
$83.80K (13)
—
+$83.80K
33,050
$299.76K
—
Soren Thompson
VP, Business Development
$8.75K (2)
$57.63K (1)
−$48.88K
1,950
$17.69K
−63.9%
Caleb DesRosiers
Director
$29.99K (1)
—
+$29.99K
3,157
$28.63K
—
Edward Feuer
Director
$16.48K (2)
—
+$16.48K
1,000
$9.07K
—
Joy S. Goudie
Director
$2.93K (1)
—
+$2.93K
300
$2.72K
—
John Jefferies
Chief Medical Officer
— (3)
—
$0.00
26,008
$235.89K
+70.3%
Estate of Joseph Feldschuh entity
10% owner
—
—
—
2,549,455
$23.12M
−8.9%

No percentages here. DAXOR CORP reports its share count only per share class, which the XBRL frames API does not carry.